ANUHPHR91.70

Anuh Pharma Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹919 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations661.5771.7965.5
Other Income9.54.410.3
Total Income671.0776.0975.8
Expenses
+ Cost of Materials Consumed463.3510.4670.4
+ Purchases of Stock-in-Trade38.579.283.3
+ Changes in Inventories-2.510.0-5.8
+ Employee Benefit Expense23.026.333.7
+ Finance Costs0.60.50.5
+ Depreciation & Amortisation8.711.413.8
+ Other Expenses78.284.0108.7
Total Expenses610.0721.8904.6
EBITDA60.961.775.1
EBIT52.250.361.3
Profit
PBT before Exceptional Items61.054.271.1
Pretax Income61.054.271.1
+ Current Tax15.315.019.2
+ Deferred Tax-1.7-1.8-0.5
Tax Expense13.713.218.7
Net Income47.441.052.5
+ Net Income — Continuing Ops47.441.052.5
+ Other Comprehensive Income-0.00.20.2
Total Comprehensive Income47.341.252.6
Per Share
Basic EPS9.454.105.24
Diluted EPS9.454.105.24
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.00.20.2
+ Items NOT to be Reclassified to P&L-0.00.20.2
+ Tax on Items NOT to be Reclassified-0.00.10.1
Per Share — as-filed variants
Basic EPS — Continuing Operations9.454.105.24
Diluted EPS — Continuing Operations9.454.105.24
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit162.1172.0217.5
Gross Margin %24.5122.2922.53
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)61.054.271.1
Net Income Adj (tax-effected)47.441.052.5
EPS Adj9.454.105.24
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value5.005.005.00
Paid Up Equity Capital25.150.150.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.